Is the tricuspid position suitable for testing replacement bioprosthetic valves in the sheep model?

Journal of Heart Valve Disease

Volumn 10, Issue 4, 2001, Pages 513-519

  Pettenazzo, E ^a   Thiene, G ^a   Gatti, A M ^a   Pasquino, E ^a   Talenti, E ^a   Noera, G ^a   Bottio, T ^a   Valente, M ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; CALCIUM; GLUTARALDEHYDE; HOMOCYSTEIC ACID; SULFONE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BACTERIAL ENDOCARDITIS; BIOCOMPATIBILITY; CALCIFICATION; CHEMICAL BINDING; CONTROLLED STUDY; CROSS LINKING; DEVICE; EXPLANT; GROWTH; HEART VALVE BIOPROSTHESIS; HEART VALVE REPLACEMENT; HISTOLOGY; MICROSCOPY; MINERALIZATION; MITRAL VALVE; NONHUMAN; PERICARDIUM; PRIORITY JOURNAL; REPRODUCIBILITY; SCANNING ELECTRON MICROSCOPY; SHEEP; STANDARD; SUBCUTANEOUS TISSUE; TISSUE FIXATION; TISSUE PRESERVATION; TOXICITY; TRICUSPID VALVE; TRICUSPID VALVE STENOSIS; ULTRASTRUCTURE; X RAY; XENOGRAFT;

ANIMALS; BIOPROSTHESIS; CALCINOSIS; CALCIUM; GRAFT SURVIVAL; HEART VALVE PROSTHESIS IMPLANTATION; HOMOCYSTEINE; MODELS, ANIMAL; RATS; SHEEP; TIME FACTORS; TRICUSPID VALVE;

EID: 0034914891     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Calcific degeneration as the main cause of porcine bioprosthetic valve failure
2. Pathology of the Pericarbon® bovine pericardial xenograft implanted in humans
3. Valve replacement in children. A fifteen-year perspective
4. Future directions in tissue heart valves: Impact of recent insights from biology and pathology
5. Aldehyde tanning: The villain in bioprosthetic heart valve calcification
6. Glutaraldehyde and the calcification mechanism of bioprosthetic heart valves
7. Time-dependent effect of glutaraldehyde on the tendency to calcify of both autografts and xenografts
8. Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material
9. Improved spontaneous endothelization by postfixation treatment of bovine pericardium
10. Improved postfixation treatment of glutaraldehyde fixed porcine aortic valves by monosodium glutamate
11. Calcification of pericardial tissue pretreated with different amino acids
12. Detoxified glutaraldehyde cross-linked pericardium: Tissue preservation and mineralization mitigation in a subcutaneous rat model
13. Detoxification process for glutaraldehyde treated bovine pericardium: Biological, chemical and mechanical characterization
14. Role of mechanical stress in calcification of aortic bioprosthetic valves
15. Calcification and stress distribution in bovine pericardial heart valves
16. Current progress in anticalcification for bioprosthetic and polymeric heart valves
17. Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate
18. Prevention of leaflet calcification of bioprosthetic heart valves with diphosphonate injection therapy. Experimental studies of optimal dosages and therapeutic durations
19. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: Preincubation and controlled release studies
20. Experimental evaluation of porcine-valved conduits processed with a calcium retarding agent (T6)
21. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms
22. Repopulation of freeze-dried porcine valves with human fibroblasts and endothelial cells
23. Effects of metallic ions and diphosphonates on inhibition of pericardial bioprosthetic tissue calcification and associated alkaline phosphatase activity
24. Calcium mitigation in bioprosthetic tissue by iron pretreatment: The challenge of iron leaching
25. Feasibility evaluation of a new pericardial bioprosthesis with dye mediated photo-oxidized bovine pericardial tissue
26. Studies on epoxy compound fixation
27. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves
28. Morphological survey of a new pericardial prosthesis (Pericarbon): Long-term animal experimental model
29. Ten-years' clinical experience with the Sorin Pericarbon valve
30. Long-term performance of the Hancock porcine bioprosthesis in the tricuspid position
31. Onset and progression of calcification in porcine aortic bioprosthetic valves implanted as orthotopic mitral valve replacements in juvenile sheep
32. FDA's requirements for in-vivo performance data for prosthetic heart valves
33. Current state of in vivo preclinical heart valve evaluation